Stock LDX LUMOS DIAGNOSTICS HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Lumos Diagnostics Holdings Limited

Equities

LDX

AU0000157091

Market Closed - Australian S.E.
Other stock markets
 02:10:52 2024-07-17 am EDT 		5-day change 1st Jan Change
0.043 AUD 0.00% Intraday chart for Lumos Diagnostics Holdings Limited -6.52% -41.10%
Jul. 09 Lumos Diagnostics Expands Distribution Deal with Henry Schein for Respiratory Infection Test MT
Jul. 04 Lumos Diagnostics Expands Distribution Deal with Regional Health Care Group for Respiratory Infection Test MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Lumos Diagnostics Expands Distribution Deal with Henry Schein for Respiratory Infection Test
MT
Lumos Diagnostics Expands Distribution Deal with Regional Health Care Group for Respiratory Infection Test
MT
Lumos Diagnostics Receives $400,000 in Milestone Payment from Hologic; Shares Up 3%
MT
Lumos Diagnostics Receives Second Payment Under IP Agreement; Shares Up 8%
MT
Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%
MT
Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children with Febrile Respiratory Infections, Study Shows
MT
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Lumos Diagnostics Hires Henry Schein as US Distributor for Respiratory Infection Blood Test; Shares Rise 4%
MT
Lumos Diagnostics' Q4 Revenue Jumps 55%
MT
Australian Shares Rise Ahead of US Inflation Data
MT
Lumos Diagnostics Signs Development and IP Agreements with Hologic; Shares Up 24%
MT
Lumos Signs Major Development and IP Agreements with Hologic, Inc
CI
Lumos Diagnostics Raises AU$2.7 Million to Support US Launch of FebriDx, ViraDx; Shares Down 6%
MT
US FDA Grants Emergency Use Authorization for Lumos Diagnostics' ViraDx
MT
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Lumos Diagnostics Secures Europe, Japan Patents for Core Camera Reader
MT
Lumos Diagnostics Expands FebriDx Market to Netherlands
MT
Lumos Diagnostics Announces Core Camera Reader Patent Granted in Europe and Japan
CI
Lumos Diagnostics Secures R&D Tax Rebate for Fiscal Year 2022
MT
Lumos Diagnostics Signs Partnership with Henry Schein Medical for FebriDx Distribution; Shares Jump 8%
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LDX Stock
  4. News Lumos Diagnostics Holdings Limited